Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marschner

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Clinical Trials (London, England)|March 27, 2010
Regional differences in multinational clinical trials: anticipating chance variationIan C Marschner
Biometrics|January 10, 1998
A method for assessing age-time disease incidence using serial prevalence dataI C Marschner
Epidemiology and Infection|May 19, 2020
Back-projection of COVID-19 diagnosis counts to assess infection incidence and control measures: analysis of Australian dataI C Marschner
Lancet (London, England)|January 4, 2025
Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trialIan C Marschner
BMC Medical Research Methodology|June 22, 2021
Estimating age-specific COVID-19 fatality risk and time to death by comparing population diagnosis and death patterns: Australian dataIan C Marschner
Cardiology|May 21, 2011
Assessment of statistical heterogeneity in the PLATO trialMarc Buyse, Ian C Marschner
Statistics in Medicine|January 29, 2000
Joint analysis of HIV and AIDS surveillance data in back-calculationR Bellocco, I C Marschner
Statistics in Medicine|May 20, 2003
Interim analysis of continuous long-term endpoints in clinical trials with longitudinal outcomesSally Galbraith, Ian C Marschner
Controlled Clinical Trials|June 12, 2002
Guidelines for the design of clinical trials with longitudinal outcomesSally Galbraith, Ian C Marschner
Biostatistics (Oxford, England)|September 15, 2011
Relative risk regression: reliable and flexible methods for log-binomial modelsIan C Marschner, Alexandra C Gillett
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Clinical Trials (London, England)|March 27, 2010
Regional differences in multinational clinical trials: anticipating chance variationIan C Marschner
Biometrics|January 10, 1998
A method for assessing age-time disease incidence using serial prevalence dataI C Marschner
Epidemiology and Infection|May 19, 2020
Back-projection of COVID-19 diagnosis counts to assess infection incidence and control measures: analysis of Australian dataI C Marschner
Lancet (London, England)|January 4, 2025
Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trialIan C Marschner
BMC Medical Research Methodology|June 22, 2021
Estimating age-specific COVID-19 fatality risk and time to death by comparing population diagnosis and death patterns: Australian dataIan C Marschner
Cardiology|May 21, 2011
Assessment of statistical heterogeneity in the PLATO trialMarc Buyse, Ian C Marschner
Statistics in Medicine|January 29, 2000
Joint analysis of HIV and AIDS surveillance data in back-calculationR Bellocco, I C Marschner
Statistics in Medicine|May 20, 2003
Interim analysis of continuous long-term endpoints in clinical trials with longitudinal outcomesSally Galbraith, Ian C Marschner
Controlled Clinical Trials|June 12, 2002
Guidelines for the design of clinical trials with longitudinal outcomesSally Galbraith, Ian C Marschner
Biostatistics (Oxford, England)|September 15, 2011
Relative risk regression: reliable and flexible methods for log-binomial modelsIan C Marschner, Alexandra C Gillett
Pageof 10